Analysis shows blacks have poorer diabetes control than whites

August 25, 2006

WINSTON-SALEM, N.C. - An analysis combining 11 separate research studies found that blacks with diabetes have poorer control of blood sugar than whites, according to researchers from Wake Forest University School of Medicine and colleagues.

"This lower level of control may partly explain why blacks have disproportionately higher rates of death and complications from diabetes," said Julienne Kirk, PharmD, lead author of the study published online today (Aug. 25) in Diabetes Care.

Kirk said the findings point to the need to determine why the difference in control exists and to identify ways to prevent or reduce the resulting health problems. Poor blood sugar control can result in long-term complications such as blindness, amputation and end-stage kidney failure.

The researchers analyzed studies that measured sugar control among blacks and whites using a blood test for glycosylated hemoglobin - hemoglobin that has linked with glucose, or blood sugar. The lower the amounts of glycosylated hemoglobin, also called A1C, in the blood, the better the body is controlling blood sugar.

By combining the data from the 11 studies into a "meta-analysis" involving a total of 42,273 white and 14,670 black patients, they were able to detect differences that may not have shown up in each individual study. This was the first meta-analysis of racial and ethnic differences in blood sugar control among patients with diabetes.

Most of the studies included patients over age 50 with type 2 diabetes, the most common form of diabetes in which the body does not produce enough insulin or cells ignore the insulin. As a result, glucose, or sugar, builds up in the bloodstream.

The analysis focused on studies between 1993 and 2005 because the A1C measurement became more standardized during that time. Measuring A1C provides information about average blood sugar control for the previous three months and gives health care providers and patients a good idea of well how their diabetes treatment plan is working.

The researchers found that whites had about 0.65 percent less A1C than blacks. Previous research has shown that for every 1 percent reduction in A1C, there is a 21 percent reduction in any complication of diabetes. So whites in this study had a risk of complications that was 15 percent lower than blacks.

Previous studies have suggested that blood sugar control may be poorer among minority populations. Possible reasons include differences in quality of care, including the intensity of treatment; socioeconomic differences, such as being less likely to have prescription drug coverage, and genetic differences. The researchers were not able to examine these factors in their study, and said additional research is needed.

"Although A1C control among blacks likely contributes to their elevated risk of complications, it accounts for only a portion," said Kirk, an associate professor of family and community medicine. "We need to understand more fully why this disparity exists and to eliminate factors that may be changeable, such as improving access to care."
Funders of the research included the Centers for Disease Control and Prevention and the Association of Teachers of Preventive Medicine.

Kirk's co-researchers were Ralph B. D'Agostino Jr., Ph.D., Ronny Bell, Ph.D., Leah Passmore, M.S., and Denise Bonds., M.D., M.P.H., all with Wake Forest, Andrew Karter, Ph.D., with Kaiser Permanente in Oakland, Calif., and K.M. Venkat Narayan, M.D., M.P.H., M.B.A., previously with the National Center for Chronic Disease Prevention and Health Promotion and now at Emory University in Atlanta, Ga.

Media Contacts: Karen Richardson,; Shannon Koontz,, at 336-716-4587.

Wake Forest University Baptist Medical Center is an academic health system comprised of North Carolina Baptist Hospital and Wake Forest University Health Sciences, which operates the university's School of Medicine. U.S. News & World Report ranks Wake Forest University School of Medicine 18th in family medicine, 20th in geriatrics, 25th in primary care and 41st in research among the nation's medical schools. It ranks 32nd in research funding by the National Institutes of Health. Almost 150 members of the medical school faculty are listed in Best Doctors in America.

Wake Forest Baptist Medical Center

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to